Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis (scientific article published on 15 April 2015)

Culture-independent analysis of bacterial fuel contamination provides insight into the level of concordance with the standard industry practice of aerobic cultivation

Q28743046

Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy

Q29547619

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

Q33310144

Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP).

Q33373691

Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches

Q33430526

The changing microbial epidemiology in cystic fibrosis

Q33825634

In silico analysis of complete bacterial genomes: PCR, AFLP-PCR and endonuclease restriction

Q33975413

Decade-long bacterial community dynamics in cystic fibrosis airways

Q34209009

Molecular microbial diversity in soils from eastern Amazonia: evidence for unusual microorganisms and microbial population shifts associated with deforestation

Q34431539

Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy

Q34554419

Molecular diagnosis of medical viruses.

Q34626706

Culture-based diagnostic microbiology in cystic fibrosis: can we simplify the complexity?

Q35008296

Emerging cystic fibrosis pathogens and the microbiome

Q35169553

STAMP: statistical analysis of taxonomic and functional profiles.

Q35212955

Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

Q35536317

Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota

Q36187491

Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis

Q37502050

Studying bacterial infections through culture-independent approaches.

Q37531541

Direct culture-independent Strain typing of Burkholderia cepacia complex in sputum samples from patients with cystic fibrosis

Q40345571

Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis

Q42262413

Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients

Q46131950

Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum

Q46277042

Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.

Q50561588

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

Q51711090

Cystic fibrosis

Q55881299

Enacyloxins Are Products of an Unusual Hybrid Modular Polyketide Synthase Encoded by a Cryptic Burkholderia ambifaria Genomic Island

Q57590249

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

Q57913654

Use of the 16S–23S ribosomal genes spacer region in studies of prokaryotic diversity

Q59333087

Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa

Q67285991

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

biodiversity

cystic fibrosis

emerging pathogen

microbial diversity

page(s)

2022-2029

P577

publication date

2015-04-15

P1433

published in

Journal of Clinical Microbiology

Q4041880

P1476

title

Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis

P478

volume

Reverse relations

cites work (P2860)

Q89013298	"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis
Q96231866	Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
Q35946121	Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease
Q58732428	Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
Q35631188	Assessing Airway Microbiota in Cystic Fibrosis: What More Should Be Done?
Q55240269	Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity.
Q64116297	Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
Q54314356	Changes in the Cystic Fibrosis Airway Microbiome after Lung Transplant: The More Things Change, the More They Stay the Same.
Q40252432	Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.
Q36008670	Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.
Q36620854	Culture-Based and Culture-Independent Bacteriologic Analysis of Cystic Fibrosis Respiratory Specimens
Q52858752	Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New.
Q36163849	Data Mining of Lung Microbiota in Cystic Fibrosis Patients
Q59355842	Decreased microbiome diversity in the HIV small airway epithelium
Q55287506	Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.
Q36128764	In vitro model of production of antibodies; a new approach to reveal the presence of key bacteria in polymicrobial environments
Q47653765	Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children.
Q39252980	Integrating the microbiota of the respiratory tract with the unified airway model
Q40179391	Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.
Q35862783	Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies
Q36135913	Linking microbiota and respiratory disease
Q85844811	Lung mapping seeks to crack microbial code in cystic fibrosis
Q46244354	Microbial diversity within the airway microbiome in chronic pediatric lung diseases
Q52367440	On Burkholderiales order microorganisms and cystic fibrosis in Russia.
Q60303723	Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease
Q26768244	Respiratory Microbiome of New-Born Infants
Q38702812	Respiratory microbiota and lower respiratory tract disease.
Q36304192	Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa
Q54205691	The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial.
Q97644506	The Respiratory Microbiome in Cystic Fibrosis: Compartment Patterns and Clinical Relationships in Early Stage Disease
Q92458688	The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions
Q39217321	The endotracheal tube microbiome associated with Pseudomonas aeruginosa or Staphylococcus epidermidis.
Q90178697	Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation
Q89554865	mSphere of Influence: a Community To Study Communities

P356	DOI	10.1128/JCM.00432-15
P8608	Fatcat ID	release_zd73y62x25gknii2yt5wwt7x3m
P932	PMC publication ID	4473198
P698	PubMed publication ID	25878338